Quartel Adrian W 4
4 · Acer Therapeutics Inc. · Filed Feb 23, 2022
Insider Transaction Report
Form 4
Quartel Adrian W
Chief Medical Officer
Transactions
- Award
Employee Stock Option (right to buy)
2022-02-21+200,000→ 200,000 totalExercise: $2.55Exp: 2032-02-21→ Common Stock (200,000 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable over four years as follows: 25% of the shares vest on February 21, 2023, and the remaining 75% of the shares vest quarterly over the remainng three years.